BOSTON BIO SYSTEMS LTD. P/E Ratio
BOSTON BIO SYSTEMS LTD. (BOSTONBIO) P/E ratio is not applicable — EPS (TTM) ₹-0.78. See Healthcare Services peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-0.78
Healthcare Services Peers with Valid P/E Ratios — BOSTONBIO Comparison
Healthcare Services sector average P/E 95.55, median 43.64 — BOSTONBIO excluded (negative EPS).
Sector Average PE
95.55
Sector Median PE
43.64
Lowest PE
8.81
Profitable Companies
58
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.81 | ₹167 | Low |
| Abate AS Industries | ABATEAS | 11.54 | ₹140 | Low |
| Deccan Health Care | DECCAN | 12.09 | ₹32 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.5 | ₹19 | Low |
| Shanmuga Hospital | SHANMUGA | 14.27 | ₹64 | Low |
| One Global Service Provi… | ONEGLOBAL | 16.82 | ₹1,163 | Moderate |
| Invicta Diagnostic | INVICTA | 17.28 | ₹88 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 18.19 | ₹3,390 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 18.28 | ₹1,083 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.59 | ₹1,752 | Moderate |
Related Analysis
- For live price, revenue and the complete fundamental profile, see BOSTONBIO screener.
- Compare with BOSTONBIO DCF valuation to assess whether the stock is under or overvalued.
- View BOSTONBIO annual price range for the annual high/low range and current price position.